Shopping Cart
Remove All
Your shopping cart is currently empty
Romilkimab (Synonyms: SAR156597)
Catalog No. T80610 Copy Product Info
🥰Excellent
Romilkimab (SAR156597) is a chimeric humanized immunoglobulin (Ig) antibody specifically designed to target interleukins 4 and 13 (IL-4 and IL-13) [1].
Romilkimab
Copy Product Info🥰Excellent
Catalog No. T80610
Synonyms SAR156597
Romilkimab (SAR156597) is a chimeric humanized immunoglobulin (Ig) antibody specifically designed to target interleukins 4 and 13 (IL-4 and IL-13) [1].
Romilkimab
Cas No. 1399584-78-1
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Storage & Solubility Information
| Description | Romilkimab (SAR156597) is a chimeric humanized immunoglobulin (Ig) antibody specifically designed to target interleukins 4 and 13 (IL-4 and IL-13) [1]. |
| Synonyms | SAR156597 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | IL-4/IL-13 |
| Cas No. | 1399584-78-1 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Romilkimab | purchase Romilkimab | Romilkimab cost | order Romilkimab
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.